Tuesday, October 16, 2012 8:04:09 PM
RXPC ~ You said....
So if GDX can't even come up with that type of money in months, how would something like that be a blockbuster for the company?
You are right, in my opinion GCDx is small potatoes and anything but a blockbuster in comparison to what is going on behind the scenes. The fact that GCDx was unable to raise the money is no fault or foul with RXPC. GCDx is still highly interested in completing/pursuing the deal. The following excerpt from the most recent 8-K makes that apparent....
As of October 1, 2012, GCDx has not made the required upfront payment of $280,000. Therefore the proposed GCDx licensing agreement was
cancelled. We will consider re-engaging GCDx in a new licensing agreement at such time as GCDx is able to make the required up-front
payment.
Like I had said, I am not overly excited with the GCDx deal. I feel there is something much bigger taking place here. I like the below excerpt from the most recent 8-K...
From an operational perspective, we continue to sell and ship Onko-Sure test kits to the following territories: Korea, Turkey, Taiwan, India,
Vietnam, and the U.S. Despite significant financial hardship, the Company continues to maintain its operations in Tustin, relying on selective
former employees that continue to work as consultants to the Company. We are also engaged in business discussions with other companies
seeking to license Onko-Sure for various international territories. These licensing agreements, if completed, are anticipated to provide the
Company with the funds necessary to regain compliance with our public filing requirements and to begin to pay down various overdue
accounts payable. There can be no guarantee that any new licensing transactions will be completed.
Companies plural, there seems to be more than one entity interested in licensing Onko-Sure, as is noted in the most recent 8-K. I think there are big things brewing. Can't wait to get the specifics.
IMO
So if GDX can't even come up with that type of money in months, how would something like that be a blockbuster for the company?
You are right, in my opinion GCDx is small potatoes and anything but a blockbuster in comparison to what is going on behind the scenes. The fact that GCDx was unable to raise the money is no fault or foul with RXPC. GCDx is still highly interested in completing/pursuing the deal. The following excerpt from the most recent 8-K makes that apparent....
As of October 1, 2012, GCDx has not made the required upfront payment of $280,000. Therefore the proposed GCDx licensing agreement was
cancelled. We will consider re-engaging GCDx in a new licensing agreement at such time as GCDx is able to make the required up-front
payment.
Like I had said, I am not overly excited with the GCDx deal. I feel there is something much bigger taking place here. I like the below excerpt from the most recent 8-K...
From an operational perspective, we continue to sell and ship Onko-Sure test kits to the following territories: Korea, Turkey, Taiwan, India,
Vietnam, and the U.S. Despite significant financial hardship, the Company continues to maintain its operations in Tustin, relying on selective
former employees that continue to work as consultants to the Company. We are also engaged in business discussions with other companies
seeking to license Onko-Sure for various international territories. These licensing agreements, if completed, are anticipated to provide the
Company with the funds necessary to regain compliance with our public filing requirements and to begin to pay down various overdue
accounts payable. There can be no guarantee that any new licensing transactions will be completed.
Companies plural, there seems to be more than one entity interested in licensing Onko-Sure, as is noted in the most recent 8-K. I think there are big things brewing. Can't wait to get the specifics.
IMO
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
